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New lanthanide(III) complexes with 2-[2-hydroxy-3-methoxyphenyl]-3-[hydroxyl-3-methoxybenzylamino]-1,2-dihydroquin-
azoline-4(3H)-one (Hmpbaq) have been synthesized and characterized by elemental analysis, conductance measurements, mag-
netic susceptibilities, spectroscopic (IR, NMR, UV, EPR), and thermal studies. Molar conductance studies indicate 1 : 1 elec-
trolytic behavior for these complexes. IR spectra indicate that Hmpbaq acts as a tridentate ligand coordinating through car-
bonyl oxygen, benzyl amine nitrogen, and deprotonated phenolic oxygen. TG and DTA studies of La(III) and Pr(III) com-
plexes indicate the presence of two coordinated water molecules. Based on these studies, the complexes have been formulated
as [La(mpbaq)2(H2O)2]·NO3, where Ln = La(III), Pr(III), Nd(III), Sm(III), Eu(III), Gd(III), Th(III), Dy(III), and Y(III). The
ligand, lanthanide(III) salts, and the corresponding complexes have been simultaneously screened for their antibacterial and anti-
fungal activities and compared with the drugs in use.
Copyright © 2007 Kalagouda B. Gudasi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Lanthanide ion is a subject of increasing interest in bioinor-
ganic and coordination chemistry. A sustained research ac-
tivity has been devoted to lanthanide complexes, because of
their successful application as diagnostic tools in biomedi-
cal analysis as MRI contrast agents [1, 2]. They have been
used even as eﬀective catalysts for the hydrolytic cleavage of
phosphate ester bonds [3]. Lanthanide complexes have been
found to exhibit anticancer, and fungicidal properties also
[4]. Quinazolines as a class of heterocyclic compounds con-
tain the pyrimidine nucleus in their structures. A majority
of them have great therapeutic signiﬁcance due to their high
biological activity. 4(4H)-quinazolines have been tested suc-
cessfully against cancer and HIV virus [5, 6]. The synthetic
analogues of quinazolines have been found to exhibit anti-
malarial [7], anti-inﬂammatory [8], and anticancer activity
[9]. They show potent and speciﬁc inhibitory action against
leukemia cells [10]. Sulfonate ester-containing quinazoline
derivatives [11] were found to act as antimicrobial agents.
Apartfromtheabove,2,3-disubstitutedquinazoline-4-(3H)-
ones have been reported for their wide variety of pharma-
cological activity [12, 13]. The title ligand Hmpbaq pos-
sesses multiple coordinating sites such as phenolic oxygen,
carbonyl oxygen, nitrogen of the benzoyl amino group, and
nitrogen of the quinazoline ring. It may act as a monoden-
t a t e ,b i d e n t a t e ,o rt r i d e n t a t es p e c i e s .W eh a v eo b s e r v e di t s
tridentatingbehaviorwithtransitionmetalions[14].Incon-
tinuation of our work on quinazolines, here we report the
conformational changes in the ligand on coordination with
lanthanides and the relative antimicrobial activity.
2. MATERIALS AND METHODS
2.1. Chemistry
All the solvents used were of analytical grade. Hydrazine
hydrate, methyl 2-aminobenzoate, and o-vanillin were pro-
cured from Rankem, Merck, and Himedia, respectively. O-
aminobenzoyl hydrazide was synthesized as reported ear-
lier [14]. The lanthanide nitrates were obtained by heat-






























































Figure 1: The numbering system of the ligand Hmpbaq.
Mumbai, India) with dilute nitric acid (50%) and evaporat-
ing the excessive acid.
Syntheses
The ligand Hmpbaq was synthesized as in our earlier re-
port [14] (see Scheme 1). The numbering system of the lig-
and Hmpbaq is given in Figure 1. A solution of Ln(NO3)3
(1mmol) and Hmpbaq 0.838gm (2mmol) was reﬂuxed in
ethanol (25mL) for 2-3 hours. The pH of the solution was
then raised to 6.5 by the addition of sodium acetate and
reﬂuxed further for an hour. The precipitate obtained after
concentrating the solution was ﬁltered oﬀ, washed with wa-
ter, and dried in air (yield: 90%, mp > 245◦C).
Physicalmeasurements
Elemental analysis was performed on a Carlo Erba Strumen-
tazione (Milan, Italy) CHN analyzer. IR spectra were ob-
tained on a Nicolet 170 SX FT-IR spectrometer using KBr
pellets, in the range 400–4000cm−1. 1H- and 13C NMR spec-
tra were monitored on a JEOL-AMX-400 NMR spectrome-
ter, using DMSO-d6 as the solvent. TG/DTA were recorded
on a PerkinElmer (Mass, USA) (Pyris Diamond) analyzer
in N2 atmosphere at a heating rate of 10◦C. Mass spec-
tra of the ligand and complex were recorded on a Ther-
moﬁnnigan 1020-automated GCMS and JEOL SX 102/DA-
6000 mass spectrometer/data system using argon and xenon
(6kv, 10ma) as the FAB gas, respectively. UV-Visible spectra
were obtained on a Hitachi 2001 spectrometer. EPR spectra
of the Gd(III) and Tb(III) complexes were monitored on a
Varian E-4X band spectrometer. Molar conductivities were
obtained on an Elico conductivity bridge having platinum
electrodes. Magnetic moments were measured with a Fara-
day balance using Hg[Co(NCS)4] as calibrant. Diamagnetic
corrections were made using Pascal constants. The metal
contents were determined by complexometric titrations with
EDTA using xylene orange as an indicator.
2.2. Pharmacology
Antibacterialactivity
The antibacterial activity of the ligand, metal salts, and
the corresponding complexes were assayed simultaneously
against Pseudomonas aeruginosa (PA), Bacillus cirroﬂag-
ellosus (BC), by cup-plate method [15]. Nutrient broth
was prepared by dissolving peptone (0.5%), yeast extract
(0.15%), beef extract (0.15%), sodium chloride (0.36%),
and monopotassium phosphate (0.13%) in distilled water
(100mL). The pH of the solution was adjusted to 7.2 by
adding sodium hydroxide solution (4%) and the resulting
solution was autoclaved for 20 minutes at 15 psi. One day
prior to the experiment, the cultures of Pseudomonas aerug-
inosa and Bacillus cirroﬂagellosus were inoculated in nutri-
ent broth (inoculation medium) and incubated overnight
at 37◦C. Nutrient agar medium was prepared by dissolving
peptone (1%), yeast extract (0.6%), beef extract (0.5%), and
sodium chloride (0.5%) in distilled water. The pH of the so-
lution was adjusted to 7.2 by adding 4% aqueous sodium hy-
droxide solution. Agar (2.4%) was then added and the whole
solution was autoclaved for 20 minutes at 15 psi. Each test
sample (1mg) was dissolved in DMSO (1mL), and 0.1mL
of this solution (10μg) was used for testing. Inoculation
mediumcontaining24-hoursgrownculturewasaddedasep-
tically to the nutrient medium and mixed thoroughly to get
the uniform distribution. This solution was poured (25mL
in each dish) into Petri dishes and then allowed to attain
room temperature. Thereafter, punching the set of agar with
a sterile cork borer and scooping out the punched part made
the cups. The diameter of each cup was 5mm. NorﬂoxacinKalagouda B. Gudasi et al. 3
Table 1: Elemental analysis magnetic and conductance data of Hmpbaq and its Ln(III) complexes.
Sl. no. Compounds Found (calculated) % Magnetic moments Molar conductance Ohm−1cm2mol−1
MCH N
1H m p b a q ( C 23H21N3O6)— 65.86 5.03 10.03 ——
(65.87) (5.01) (10.02)
2 [La(mpbaq)2(H2O)2]·NO3
12.90 51.45 4.00 9.10 Dia 44.58
(12.94) (51.44) (4.10) (9.13)
3 [Pr(mpbaq)2(H2O)2]·NO3
13.00 51.30 4.15 9.15 3.86 45.28
(13.10) (51.35) (4.09) (9.11)
4[ N d ( m p b a q ) 2(H2O)2]·NO3
13.35 51.25 4.01 9.16 3.52 47.23
(13.37) (51.19) (4.08) (9.08)
5[ S m ( m p b a q ) 2(H2O)2]·NO3
13.85 50.85 4.10 9.06 1.70 47.58
(13.86) (50.90) (4.05) (9.03)
6[ E u ( m p b a q ) 2(H2O)2]·NO3
13.95 50.75 4.00 8.98 3.80 48.02
(13.99) (50.83) (4.05) (9.02)
7 [Gd(mpbaq)2(H2O)2]·NO3
14.45 50.55 4.00 9.00 7.90 47.28
(14.41) (50.58) (4.03) (8.98)
8[ T b ( m p b a q ) 2(H2O)2]·NO3
13.60 50.60 4.10 8.95 9.80 49.58
(14.54) (50.50) (4.02) (8.96)
9[ D y ( m p b a q ) 2(H2O)2]·NO3
14.90 50.34 4.08 8.90 10.82 49.20
(14.81) (50.34) (4.01) (8.93)
10 [Y(mpbaq)2(H2O)2]·NO3
8.70 53.98 4.25 9.55 Dia 47.50
(8.69) (53.96) (4.30) (9.58)
was used as the standard and DMSO as the solvent control.
The test samples and the standard were tested at a concen-
tration of 10μg. The plates were allowed to stand for an hour
in order to facilitate the diﬀusion of the drug solution. Then
the plates were incubated at 37◦C for 48 hours. The zones of
inhibition against all the microorganisms were measured in
millimeters.
Antifungalactivity
The antifungal activity of the ligand and the corresponding
metal complexes weretested against thepathogenic fungiAs-
pergillus niger (AN) and Penicillium notatum (PN) by cup-
plate method. Nutrient agar medium was prepared by the
same method as explained under evaluation of antibacte-
rial activity. One and half day prior to the experiment, the
fungal cultures of Aspergillus niger and Penicillium notatum
prepared in the inoculation medium were incubated at 37◦C
for 36 hours. The fungal medium was prepared by dissolv-
ing peptone (0.5%), sodium chloride (0.36%), monopotas-
sium phosphate (0.13%), and glucose (2%) in distilled wa-
ter (100mL). The pH of the solution was adjusted to 7.2 by
adding sodium hydroxide solution (4%) and the resulting
solution was autoclaved for 20 minutes at 15 psi. This was
cooled to 45–50◦C with gentle shaking. One and half day,
g r o w nc u l t u r e sw e r ea d d e da s e p t i c a l l yt ot h i sm e d i u ma n d
mixed thoroughly to get uniform distribution. The solutions
of the test samples and standard were evaluated for antifun-
gal activity by cup-plate method at a concentration of 10μg.
The zone of inhibition was measured in millimeter for the
particular test sample with each organism at 48 hours inter-
val. Griseofulvin was used as the standard.
3. RESULTS AND DISCUSSION
3.1. Chemistry
The analytical data (see Table 1) indicate that the complexes
have 1 : 2 (metal : ligand) stoichiometry and can be repre-
sented by the general formula [La(mpbaq)2(H2O)2]·NO3.
The lanthanide complexes are stable, nonhygroscopic, and
yellow in color. They are soluble in DMSO and DMF, spar-
ingly soluble in ethanol and methanol, but insoluble in ben-
zene, ether, and chloroform. The molar conductance data
(see Table 1) of the complexes in DMSO at 10−3 M is in the
range of 44.00–49.00ohm−1cm2mol−1, which indicates 1 : 1
electrolytic nature of the complexes.
3.2. Infraredspectra
The diagnostic IR frequencies of the ligand Hmpbaq and
its complexes are compiled in Table 2. In the spectrum of
the Hmpbaq, the strong band observed at 1653cm−1 is as-
signed to ν(C=O) of the quinazoline ring. The appearance
of this band at a lower wave number is due to the exis-
tence of strong intermolecular hydrogen bonding between
the oxygen of C=O and the hydrogen of the 2-[2-hydroxy-
3-methoxy phenyl) group, as observed in its crystal struc-
ture [14]. The band at 1610cm−1 is assigned to benzyl amine
ν(C=N). The two nonequivalent phenolic −OH groups are
observed at 3460–2940cm−1 as a strong unresolved broad4 Metal-Based Drugs
Table 2: Diagnostic IR frequencies of the ligand Hmpbaq and its complexes.
Sl. no. Compound ν(OH) of water ν(NH) Quinazoline ν(C=O) Phenolic ν(OH) ν(C=N) IonicNO3
1 Hnpbaq 3518b 3314s 1653s 3065b 1616s —
2 [La(mpbaq)2(H2O)2]·NO3 3425b noa 1640s nob 1572sh 1381m
3 [Pr(mpbaq)2(H2O)2]·NO3 3428b noa 1638s nob 1585sh 1385m
4[ N d ( m p b a q ) 2(H2O)2]·NO3 3433b noa 1633s nob 1585sh 1383m
5[ S m ( m p b a q ) 2(H2O)2]·NO3 3430b noa 1633s nob 1585sh 1384m
6[ E u ( m p b a q ) 2(H2O)2]·NO3 3451b noa 1634s nob 1586sh 1385m
7 [Gd(mpbaq)2(H2O)2]·NO3 3429b noa 1633s nob 1586sh 1384m
8[ T b ( m p b a q ) 2(H2O)2]·NO3 3439b noa 1634s nob 1586sh 1385m
9[ D y ( m p b a q ) 2(H2O)2]·NO3 3438b noa 1633s nob 1586sh 1387m
10 [Y(mpbaq)2(H2O)2]·NO3 3428b noa 1633s nob 1586sh 1349m
s-strong, m-medium, b-broad, w-weak.
noa—not observed distinctly, might have been observed by the broad band of water molecules.
nob—not observed distinctly, might have been observed by the broad band of water molecules.
Table 3: 1H NMR spectral data of Hmpbaq and its La(III) complex.
Chemical shift in ppm
Protons Hmpbaq La(III) complex
O(3)H 11.31 (s,1H) —
O(4)H 9.42 (s,1H) 9.42 (s,1H)
C(21)H 8.43 (s,1H) 8.46 (s,1H)
C(13)H 7.81 (d,1H, J = 7.52Hz) 7.88 (d,1H, J = 7.52Hz)
N(3)H 7.43 (s,1H) 7.58 (s,1H)
C(13)H–C(5)H, C(9)H–C(11)H 7.31–6.60 (m,10 Ar–H) 7.38–6.37 (m,10 Ar–H)
and C (15)H–C(18)H,
O(3)C(22)H, and O(5)C(23)H3 3.80 (s,6H) 3.82 (s,6H)
s = singlet; d = doublet; m = multiplet; Ar–H = Aromatic protons.
band. A medium intensity band at 3280cm−1 is assigned to
ν(NH) of the quinazoline ring. In the spectra of all the com-
plexes, the ν(C=O) has shifted to lower wave numbers indi-
cating the involvement of carbonyl oxygen in coordination.
The band due to ν(C=N) has shifted to lower energy (1616–
1572cm−1), indicating coordination through benzyl amine
nitrogen.Thebandduetophenolic −OHgroupswasnotob-
servedinthespectraofthecomplexes,itmighthavebeenob-
scured by a broad band due to water. However, the coordina-
tion through only one or both of the phenolic oxygen/s was
further conﬁrmed by 1H NMR spectral studies. Strong band
at 1381cm−1 in the spectra of all the complexes indicates the
presence of ionic nitrate. The presence of coordinated wa-
ter molecules is suggested by the appearance of characteristic
rocking frequency at 825cm−1. This was further conﬁrmed
by thermal studies.
3.3. 1HNMRspectralstudies
1H NMR spectra of the Hmpbaq and its La(III) complex
were recorded in DMSO-d6 and the data along with the as-
signments are displayed in Table 3. Figure 1 gives the num-
bering system employed for 1H NMR assignments. The 1H
NMRspectrumofHmpbaqexhibitstwosharppeaksat11.31
and 9.42ppm, corresponding to O(2)H (D2O exchangeable)
and O(4)H (D2O exchangeable), respectively. Two singlets
and one doublet at 8.43, 7.43, and 7.81ppm are due to
C(21)H, N(3)H (D2O exchangeable) and C(13)H, respec-
tively. N(3)H and C(13)H, being cis to one another, coupled
together and this coupling results in the splitting of C(13)H
signal. Four triplets [C(17)H, C(16)H, C(10)H, and C(4)H]
and six doublets [C(18)H, C(15)H, C(11)H, C(9)H, C(5)H,
and C(3)H] have merged to give a multiplet at 7.31–6.6ppm
corresponding to ten aromatic protons. The resonance due
to O(3)C(22)H3 and O(5)C(23)H3 appeared at 3.85ppm.
In the spectrum of La(III) complex, the resonance due to
O(4)H has appeared at the same position as in the ligand
(9.40ppm) indicating the noninvolvement of O(4)H in the
coordination. The singlet at 11.31ppm in the ligand spec-
trum ascribed to O(2)H group is not observed in La(III)
complex. This conﬁrms the involvement of O(2)H in coor-
dination with the metal ion via deprotonation. The other
signals [C(21)H, N(3)H, C(13)H, C(17)H, C(16)H, C(10)H,
C(4)H, C(18)H, C(15)H, C(11)H, C(9)H, C(5)H, C(3)H,
O(3)C(22)H3,and O(5)C(23)H3] in La(III)complexdid not
show any considerable shift.
3.4. MagneticandEPRspectralstudies
The eﬀective magnetic moments (see Table 1)o fa l lt h ec o m -
plexes indicate that they are paramagnetic in nature ex-
cept La(III) and Y(III) which are diamagnetic. The valuesKalagouda B. Gudasi et al. 5
Table 4: UV-visible spectral data of the ligand Hmpbaq, Pr(III), and Sm(III) complexes.
Complex Assignment νmax of Ln+3 i o ni nc m −1 νmax of complexes in cm−1 β Related parameter
[Pr(mpbaq)2(H2O)2]·NO3
n→π∗ 25142 25062 0.99681 δ = 0.46919%
π→π∗ 31237 31152 0.99686 b1/2 = 0.048321
38610 38314 0.99232 η = 0.06836
β = 0.99533
[Sm(mpbaq)2(H2O)2]·NO3
n→π∗ 25642 25445 0.99231 δ = 0.72522%
n→π∗ 31250 31250 0.99376 b1/2 = 0.06
38610 38314 0.99233 η = 0.08791
β = 0.99280
obtained are similar to the Van Vleck and Frank [16]a n d
Hund’s values except in case of Sm(III) and Eu(III) where
slightly higher values were obtained. This is due to low J-J
separation, which leads to thermal population of higher en-
ergy levels. The values obtained are similar to those of typical
lanthanide ions [17] and indicate the noninvolvement of 4f
electrons in bonding due to their very eﬀective shielding by
the5s2 5p6 octet.Gd(III)ionhas4f7 electronicconﬁguration
with 8S7/2 single-ion ground state. The energy level of the
lowest excited state is very high with no contribution from
orbital angular momentum and the anisotropic eﬀect [18].
A “g” value of 1.99 (at room temperature) and 2.04 (at liq-
uid nitrogen temperature) compared to the free-ion value of
tetracynoethylene (2.00277) with broad resonance lines was
obtained. The “g” values being almost the same and simi-
lar line widths indicate that the line widths are independent
of temperature. Further, the complete absence of zero-ﬁeld
hyperﬁne splitting and the presence of broad bands indicate
that the Gd(III) ion is located in a rather disordered environ-
ment caused by strain. These strains (caused by “g” strain for
the “g” tensor distribution, D-strain for the zero ﬁeld split-
ting distribution) arise due to random hydrogen bonds be-
tween water molecules and the complex leading to distor-
tions, which lead to broad resonance EPR lines [19, 20].
3.5. UV-visiblespectra
The electronic spectral data of the two representative com-
plexes are given in Table 4. The free ligand shows an in-
tense band at 32786cm−1and two weak bands at 28328 and
38610cm−1 of which the ﬁrst two are assigned to the n→π∗
and the latter to the π→π∗ transitions, respectively. The elec-
tronic spectra of the complexes are dominated by ligand
bands, with a slight shift to higher or lower energy levels.
This slight shift was attributed to the eﬀects of crystal ﬁeld
upon the interelectronic repulsion between the 4f electrons
[21]. The bonding parameter (b1/2), Sinha’s covalence pa-
rameter (δ), nephelauxetic parameter (β), and angular co-
valence (η) have been calculated according to literature pro-
cedure [22, 23]. β values being less than unity and positive
value of b1/2 and δ indicate metal-ligand covalent bonding.
According to Karraker [24], the shape of the hypersensitive
transitionreﬂectstheenvironmentofthemetalion.Oncom-
parison of the spectra with that of known compounds, it is
concluded thatthe coordination number of the present com-
plexes is eight.
3.6. Thermalstudies
The TG/DTA study of La(III) and Pr(III) complexes was car-
ried out as the representative. In case of La(III) complex, the
initial weight loss of 11.24% (Cal. 11.34%) at 250◦Cc o r r e -
sponds to the loss of two water molecules. The temperature
ranges suggest the presence of coordinated water molecules.
The next weight loss in the temperature range of 250–350◦C
is due to the loss of one ionic nitrate molecule (Obs. 10.00%;
Cal. 10.35%). A further weight loss in the range of 350–
800◦C corresponds to two ligand molecules (Obs. 69.00%;
Cal. 69.89%). Finally, the most stable oxide was formed, on
further heating up to 1000◦C. The percentage of metal ob-
tained is in conﬁrmation with the analytical values for the
metal content.
In case of Pr(III), the thermogram exhibits a loss of
3.00% (Cal. 3.00%) corresponding to the loss of two coor-
dinated water molecules. A loss of 10.00% (Cal. 10.35%) be-
tween 240–260◦C is due to the removal of one ionic nitrate
molecule. A further weight loss of 69.00% (Cal. 69.72%) is
due to two ligand molecules. Finally, the most stable oxide
Pr6O11 is formed.
3.7. Massspectralstudies
In the present investigation, the mass spectrum of Hmpbaq
shows the formation of molecular ion peak at m/z = 419
and corresponds to the total molecular weight of the ligand.
The FAB mass spectra of [Sm(mpbaq)2(H2O)2]·NO3 and
[Eu(mpbaq)2(H2O)2]·NO3 show the molecular ion peaks at
m/z = 1084 and 1086, respectively, supporting the composi-
tion of the complexes.
3.8. Pharmacology
The results of the antibacterial and antifungal studies are
given in Table 5. The ligand Hmpbaq was less active against
PN, PA, and BC except against AN where it has shown
moderate activity. Compared to the ligand, the complexes
were moderately active against PA. All the complexes, ex-
cept La(III), Pr(III), and Nd(III) complexes, show moderate6 Metal-Based Drugs
Table 5: Inhibitory activity of Hmpbaq and its Ln(III) complexes.
Compound Antifungal Antibacterial
PN AN PA BC
Hnpbaq + ++ + +
[La(mpbaq)2(H2O)2]·NO3 ++ + ++
[Pr(mpbaq)2(H2O)2]·NO3 ++ + ++
[Nd(mpbaq)2(H2O)2]·NO3 ++ + ++
[Sm(mpbaq)2(H2O)2]·NO3 ++ + + + +
[Eu(mpbaq)2(H2O)2]·NO3 ++ + + + +
[Gd(mpbaq)2(H2O)2]·NO3 ++ + + + +
[Tb(mpbaq)2(H2O)2]·NO3 ++ + + + +
[Dy(mpbaq)2(H2O)2]·NO3 ++ + + + +
[Y(mpbaq)2(H2O)2]·NO3 ++ + + + +
Grisofulvin +++ +++ −−
Norﬂoxacin −− +++ + ++
Key to interpretation (−) = no inhibition zone = inactive; 1–5mm(+) = less active; 6–10mm(++) = moderately active; 10–15mm(+++) = highly active.





















Figure 2: Proposed structure of lanthanide(III) complex.
activity against BC. It was observed that, compared to the
ligand and metal salts, the complexes exhibited enhanced
antibacterial activity, which is due to the synergistic ef-
fect that increases the lipophilicity of the complexes. Chela-
tion decreases the polarity of the metal ion, which further
leads to the enhancement of complex’s lipophilicity. Since
the microorganism cell is surrounded by a lipid membrane
which favors the passage of lipid soluble materials, increased
lipophilicities allows the penetration of complex into and
through the membrane and deactivates the active enzyme
sites of the microorganisms [25].
4. CONCLUSION
Based on the above data, structure I is proposed for
the lanthanide(III) complexes having the general formula
[Ln(mpbaq)2(H2O)2]·NO3,w h e r eL n= La(III), Pr(III),
Nd(III), Sm(III), Eu(III), Gd(III), Tb(III), Dy(III), and
Y(III). In the present complexes, due to rotation about the
N–N bond, the ligand changes its conformation to facilitate
the coordination in ONN fashion as in the case of Cd(II)
complex as reported earlier [14]. The antibacterial activity of
the ligand is enhanced on complexation, whereas no distinct
change is observed in case of antifungal activity.
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